000 | 01202 a2200325 4500 | ||
---|---|---|---|
005 | 20250518093523.0 | ||
264 | 0 | _c20210621 | |
008 | 202106s 0 0 eng d | ||
022 | _a1523-1755 | ||
024 | 7 |
_a10.1016/j.kint.2019.12.025 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCrickx, Etienne | |
245 | 0 | 0 |
_aAnti-CD20-mediated B-cell depletion in autoimmune diseases: successes, failures and future perspectives. _h[electronic resource] |
260 |
_bKidney international _c05 2020 |
||
300 |
_a885-893 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal _xtherapeutic use |
650 | 0 | 4 | _aAntigens, CD20 |
650 | 0 | 4 |
_aAutoimmune Diseases _xtherapy |
650 | 0 | 4 | _aB-Lymphocytes |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLupus Erythematosus, Systemic |
650 | 0 | 4 | _aLymphocyte Depletion |
650 | 0 | 4 |
_aRituximab _xtherapeutic use |
700 | 1 | _aWeill, Jean-Claude | |
700 | 1 | _aReynaud, Claude-Agnès | |
700 | 1 | _aMahévas, Matthieu | |
773 | 0 |
_tKidney international _gvol. 97 _gno. 5 _gp. 885-893 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.kint.2019.12.025 _zAvailable from publisher's website |
999 |
_c30796894 _d30796894 |